[
  {
    "ts": null,
    "headline": "Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit",
    "summary": "LOS ANGELES, March 13, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Merck & Co . ...",
    "url": "https://finnhub.io/api/news?id=5d78f62ba12a640b4ad964ac3cae57456e178e890e031f5626a46df9e5c06f02",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741881972,
      "headline": "Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit",
      "id": 133163945,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "LOS ANGELES, March 13, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Merck & Co . ...",
      "url": "https://finnhub.io/api/news?id=5d78f62ba12a640b4ad964ac3cae57456e178e890e031f5626a46df9e5c06f02"
    }
  },
  {
    "ts": null,
    "headline": "MSD to push for approval of HIV combo after Phase III success",
    "summary": "MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.",
    "url": "https://finnhub.io/api/news?id=3d2f3f01c78d6ab9bd9fb9fcae2d72e73881c384e38282d1dc894ec8bba89b6c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741870187,
      "headline": "MSD to push for approval of HIV combo after Phase III success",
      "id": 133184623,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.",
      "url": "https://finnhub.io/api/news?id=3d2f3f01c78d6ab9bd9fb9fcae2d72e73881c384e38282d1dc894ec8bba89b6c"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (NYSE:MRK) Looks Interesting, And It's About To Pay A Dividend",
    "summary": "Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Merck & Co...",
    "url": "https://finnhub.io/api/news?id=ab7ef64950cb8bf74485ab28f5d869c0f9ab7bdfb2a01a1468266787e5b83905",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741864085,
      "headline": "Merck & Co., Inc. (NYSE:MRK) Looks Interesting, And It's About To Pay A Dividend",
      "id": 133184624,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Merck & Co...",
      "url": "https://finnhub.io/api/news?id=ab7ef64950cb8bf74485ab28f5d869c0f9ab7bdfb2a01a1468266787e5b83905"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co., Inc. Class Action: The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK",
    "summary": "NEW YORK, March 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. . ...",
    "url": "https://finnhub.io/api/news?id=9c54b2148339c410a8f947fef6ffcc2b830e1c6033c0328af31716b8c8eecffb",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741844786,
      "headline": "Merck & Co., Inc. Class Action: The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK",
      "id": 133161433,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "NEW YORK, March 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. . ...",
      "url": "https://finnhub.io/api/news?id=9c54b2148339c410a8f947fef6ffcc2b830e1c6033c0328af31716b8c8eecffb"
    }
  },
  {
    "ts": null,
    "headline": "They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick.",
    "summary": "They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick.",
    "url": "https://finnhub.io/api/news?id=ffcaf7ced7f6368046e3ea29b1c8d956d1fe42859fe36b9846a247e649d57096",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741843800,
      "headline": "They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick.",
      "id": 133171063,
      "image": "",
      "related": "MRK",
      "source": "DowJones",
      "summary": "They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick.",
      "url": "https://finnhub.io/api/news?id=ffcaf7ced7f6368046e3ea29b1c8d956d1fe42859fe36b9846a247e649d57096"
    }
  },
  {
    "ts": null,
    "headline": "Merck and 8 More Healthcare Stocks for Nervous Dividend Investors",
    "summary": "Merck and 8 More Healthcare Stocks for Nervous Dividend Investors",
    "url": "https://finnhub.io/api/news?id=62a9a4a6294aadec795d8cfc2b3396e777cb8e2b5f94f20c078e34809526391e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741829400,
      "headline": "Merck and 8 More Healthcare Stocks for Nervous Dividend Investors",
      "id": 133170433,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck and 8 More Healthcare Stocks for Nervous Dividend Investors",
      "url": "https://finnhub.io/api/news?id=62a9a4a6294aadec795d8cfc2b3396e777cb8e2b5f94f20c078e34809526391e"
    }
  }
]